By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 80.28 |
Change Today | -0.49 |
% Change | -0.61 % |
52 Week High | 109.62 |
52 Week Low | 78.84 |
Volume | 1,514,951 |
Shares Issued | 1,256.00m |
Market Cap | 100,832m |
Beta | 0.76 |
Strong Buy | 13 |
Buy | 7 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 1 |
Total | 27 |
You are here: research